High-fiber diet linked to reduced risk of heart disease in night shift workers: Study
People who work at night have a higher risk of coronary artery disease, a type of heart disease. A new study suggests that a higher fibre intake in the diet…
Poly-L-lysine–Coated Catheters: Effective and Safe for Prevention of Catheter-Associated UTI: Study
Researchers have found in a new study that Poly-L-lysine (PLL)–coated urinary catheters are safe, well-tolerated, and noninferior to noble metal alloy (NMA)–coated catheters in preventing bacteriuria among adults requiring short-term…
Fremanezumab Reduces Migraine Days in Children and Adolescents: NEJM
A new study published in The New England Journal of Medicine showed that Fremanezumab reduced migraine and headache days more than a placebo in children and adolescents with episodic migraine.…
MMF-Based Regimen Shows Potential as Treatment Option for juvenile dermatomyositis: JAMA
A new study published in the Journal of the American Medical Association showed that for juvenile dermatomyositis (JDM), a combination of intermittent intravenous methylprednisolone pulse and mycophenolate mofetil (MMF) may…
MAJESTY Phase 3 Trial: Obinutuzumab shows positive efficacy and safety outcomes in Primary Membranous Nephropathy
The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated positive efficacy and safety outcomes. The trial successfully met its primary endpoint, with patients achieving…
SC Seeks Centre, DCGI Response on Micro Labs’ Plea Against Anti-Diabetic FDC Ban
New Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an appeal filed by Micro Labs against the prohibition of two…
Alembic Bags USFDA Approval for USD 27 Million Lamotrigine ODT Market
New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets USP…
Dr Reddy’s Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: Report
Mumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with…
Allahabad HC Denies Bail in Phensedyl Diversion Case, Accused Directed to Surrender
Lucknow: The Allahabad High Court has refused to grant regular bail to two individuals accused in a case involving the alleged illegal storage and transportation of Phensedyl cough syrup, effectively…
Aurobindo’s Eugia Arm Secures USFDA Nod for Transplant Drug Everolimus
New Delhi: Aurobindo Pharma Limited announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) for Everolimus Tablets…
- Go to the previous page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- …
- 143
- Go to the next page